poisar

Stocks · News reference

Nephros Q2 EPS $0.11 Beats $0.00 Estimate, Sales $6.017M Beat $4.994M Estimate

BenzingaAug 6, 2026, 8:04 PMBenzinga Newsdesk

Nephros (NASDAQ:NEPH) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $0.00 by Infinity percent. This is a 450 percent increase over earnings of $0.02 per share from the same

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Aug 6, 2026, 8:04 PM
Checked
Aug 6, 2026, 8:04 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Globenewswire IncJul 20, 2026, 11:00 AMNa

    Nephros to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22nd at 10:00 a.m. ET

    Nephros, Inc. (Nasdaq: NEPH), a water technology and filtration solutions company, announced that its President and CEO Robert Banks will present at Maxim Group LLC's virtual 'Health, Wellness & Longevity' conference on July 22, 2026, at 10:00 a.m. ET. The conference brings together leaders from companies innovating in beverages, food, supplements, and longevity sectors to discuss consumer preferences and emerging trends.

    Read original at globenewswire-inc